Register entry

MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED

Data as of · How to read this entry

Registered sites
1
Active NDC listings
2
Labeller names
2
Live patents
0
Countries
1
Base
India
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
MIDAS CARE PHARMACEUTICALS PRIVATE LIMITEDPlot No. B-16, MIDC, Waluj, Aurangabad, Maharashtra 431136, India (IND)Analytical testing, Labelling, Finished drug manufacture, Packaging3007542588862273427
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human otc drug. By marketing category: OTC MONOGRAPH DRUG 2.

Dosage formNDCs
aerosol, spray2
RouteNDCs
topical2
Labeller name on the listingNDCs
midas-care pharmaceuticals pvt. ltd.1
midas-care pharmaceuticals, pvt. ltd1
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
RELISPRAY NATURAL PAIN RELIEFMentholaerosol, spray, topical46063-101OTC MONOGRAPH DRUG
Relispray Antifungal LiquidTolnaftateaerosol, spray, topical46063-810OTC MONOGRAPH DRUG
Neighbours

Registered in the same town

3
Compare

Comparable companies in India

Enquiry

Common questions

Is MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED FDA approved?
MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED holds 1 FDA-registered establishment in India. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED's drugs manufactured?
The FDA register lists Aurangabad. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED make?
2 products are listed under MIDAS CARE PHARMACEUTICALS PRIVATE LIMITED in the openFDA NDC Directory, most often as aerosol, spray. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.